Home/Stocks/HLVX

HLVX

USD

HilleVax Inc. Common Stock

$2.090-0.010 (-0.476%)

Real-time Price

Healthcare

Biotechnology

United States

Price Chart

No chart data available

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$2.100

High

$2.090

Low

$2.090

Volume

N/A

Company Fundamentals

Market Cap

104.8M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.69M

Exchange

NMS

Currency

USD

52-Week Range

Low $1.34Current $2.090High $2.17

Related News

Aug 20, 2025 · 03:02 PM

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Aug 7, 2025 · 10:34 PM

PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

Aug 6, 2025 · 08:05 PM

GlobeNewswire

HilleVax Reports Second Quarter 2025 Financial Results

BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the

Aug 5, 2025 · 10:01 PM

PR Newswire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the...

Aug 4, 2025 · 03:37 PM

PR Newswire

Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

GlobeNewswire

Aug 4, 2025 · 11:00 AM

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) and XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA) announced today they have entered